Access Resources
851 - 900 of 7616 Results
Title
Year
-
RESTRICTEDTitle: LRRK2-targeted Parkinson disease drug advances into phase IIIJournal Name: Nature Reviews Drug DiscoveryPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/d41573-022-00212-0Citation Count: 8
- Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networks2022RESTRICTEDTitle: Predictive modelling of Parkinson’s disease progression based on RNA-Sequence with densely connected deep recurrent neural networksJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-25454-1Best OA location URL: https://www.nature.com/articles/s41598-022-25454-1.pdfCitation Count: 1
-
RESTRICTEDTitle: The genetic regulation of protein expression in cerebrospinal fluidJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202216359Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202216359Citation Count: 13
- Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical Validation2022RESTRICTEDTitle: Video-Based Facial Movement Analysis in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Clinical ValidationJournal Name: Journal of Speech, Language, and Hearing ResearchPublisher: American Speech Language Hearing AssociationVol: 65Issue #: 12Start Page: 4667End Page: 4678Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2022_jslhr-22-00072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940890Citation Count: 3
- Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete Recovery2022RESTRICTEDTitle: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete RecoveryJournal Name: Annals of Otology, Rhinology & LaryngologyPublisher: SAGE PublicationsVol: 132Issue #: 10Start Page: 1177End Page: 1185Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/00034894221138485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742352Citation Count: 2
- It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum2022RESTRICTEDTitle: It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid SumJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 342End Page: 347Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29279Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974855Citation Count: 6
- Persistent depressive symptoms are associated with frontal regional atrophy in patients with Alzheimer's disease2022RESTRICTEDTitle: Persistent depressive symptoms are associated with frontal regional atrophy in patients with Alzheimer's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 38Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.5858Best OA location URL: https://research-information.bris.ac.uk/files/352878234/depression_AD_neuroimaging_paper_int_j_ger_psych_rev_2_clean.pdfCitation Count: 5
-
RESTRICTEDTitle: Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose AdjustmentJournal Name: European Medical JournalPublisher: European Medical GroupVol:Issue #:Start Page: 20End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.33590/emj/10022165Best OA location URL: https://www.emjreviews.com/wp-content/uploads/2022/12/Tailoring-Motor-Fluctuation-Treatment-Beyond-Levodopa-Dose-Adjustment-1.pdfCitation Count: 0
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022RESTRICTEDTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 5
-
RESTRICTEDTitle: Movement Disorders andSARS‐CoV‐2Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13615Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448146Citation Count: 2
- Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease2022RESTRICTEDTitle: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000201201Best OA location URL: https://n.neurology.org/content/neurology/99/23/e2548.full.pdfCitation Count: 6
-
RESTRICTEDTitle: A Severe Case of Lupus CerebritisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903100.95793.8aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S9.full.pdfCitation Count: 0
- An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies2022RESTRICTEDTitle: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 TherapiesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0aBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdfCitation Count: 0
- Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PD2022RESTRICTEDTitle: Brain and Cerebrospinal Fluid α‐Synuclein Real‐Time Quaking‐Induced Conversion Identifies Lewy Body Pathology in LRRK2‐PDJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 2Start Page: 333End Page: 338Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29284Best OA location URL: https://doi.org/10.1002/mds.29284Citation Count: 10
- Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy Controls2022RESTRICTEDTitle: Examining the Differences in Biomarkers of Neuronal and Glial Injury Between Autoimmune Neurologic Disease Patients and Healthy ControlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903096.36040.1dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S8.full.pdfCitation Count: 0
- Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects2022RESTRICTEDTitle: Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effectsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-34732-5Best OA location URL: https://www.nature.com/articles/s41467-022-34732-5.pdfCitation Count: 21
- Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 Sequences2022RESTRICTEDTitle: Protective Association of HLA-DRB1*04 Subtypes in Neurodegenerative Diseases Implicates Acetylated Tau PHF6 SequencesJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903160.72715.2dBest OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S17.1.full.pdfCitation Count: 1
- Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)2022RESTRICTEDTitle: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdfCitation Count: 1
-
RESTRICTEDTitle: Substitution of PINK1 Gly411 modulates substrate receptivity and turnoverJournal Name: AutophagyPublisher: Informa UK LimitedVol: 19Issue #: 6Start Page: 1711End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2022.2151294Best OA location URL: https://doi.org/10.1080/15548627.2022.2151294Citation Count: 8
- The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis2022RESTRICTEDTitle: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdfCitation Count: 2
- Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-Encephalitis2022RESTRICTEDTitle: Understanding Correlation of Electroclinical Findings With Functional and Neuropsychiatric Outcomes in Patients with LGI1-EncephalitisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 23_Supplement_2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.wnl.0000903424.19914.85Citation Count: 0
-
RESTRICTEDTitle: Synapsin III Regulates Dopaminergic Neuron Development in VertebratesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 23Start Page: 3902End Page: 3902Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11233902Best OA location URL: https://www.mdpi.com/2073-4409/11/23/3902/pdf?version=1669977075Citation Count: 2
-
RESTRICTEDTitle: Agglomerative and divisive hierarchical Bayesian clusteringJournal Name: Computational Statistics & Data AnalysisPublisher: Elsevier BVVol: 176Issue #:Start Page: 107566End Page: 107566Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.csda.2022.107566Citation Count: 3
- Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants2022RESTRICTEDTitle: Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 12Start Page: 102565End Page: 102565Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102565Best OA location URL: http://www.jbc.org/article/S0021925822010092/pdfCitation Count: 2
-
RESTRICTEDTitle: Bile acids and neurological diseaseJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 240Issue #:Start Page: 108311End Page: 108311Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.pharmthera.2022.108311Best OA location URL: https://doi.org/10.1016/j.pharmthera.2022.108311Citation Count: 12
- Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's disease2022RESTRICTEDTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 6
- Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI study2022RESTRICTEDTitle: Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 32End Page: 38Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.027Citation Count: 2
- Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic2022RESTRICTEDTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://doi.org/10.1242/dmm.049755Citation Count: 0
-
RESTRICTEDTitle: Comparison of manual and automated measures of walking speed: Distance and pace matterJournal Name: Experimental GerontologyPublisher: Elsevier BVVol: 170Issue #:Start Page: 111987End Page: 111987Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.exger.2022.111987Best OA location URL: https://doi.org/10.1016/j.exger.2022.111987Citation Count: 2
- Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach2022RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 6
- Effective R2 relaxation rate, derived from dual-contrast fast-spin-echo MRI, enables detection of hemisphere differences in iron level and dopamine function in Parkinson’s disease and healthy individuals2022RESTRICTEDTitle: Effective R2 relaxation rate, derived from dual-contrast fast-spin-echo MRI, enables detection of hemisphere differences in iron level and dopamine function in Parkinson’s disease and healthy individualsJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 382Issue #:Start Page: 109708End Page: 109708Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jneumeth.2022.109708Best OA location URL: https://doi.org/10.1016/j.jneumeth.2022.109708Citation Count: 5
- Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s disease2022RESTRICTEDTitle: Epidemiology meets toxicogenomics: Mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson’s diseaseJournal Name: Environment InternationalPublisher: Elsevier BVVol: 170Issue #:Start Page: 107613End Page: 107613Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.envint.2022.107613Best OA location URL: https://doi.org/10.1016/j.envint.2022.107613Citation Count: 5
-
RESTRICTEDTitle: Functional Interaction Between α-Synuclein and Nurr1 in Dopaminergic NeuronsJournal Name: NeurosciencePublisher: Elsevier BVVol: 506Issue #:Start Page: 114End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2022.10.011Citation Count: 1
- Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities2022RESTRICTEDTitle: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental DisabilitiesJournal Name: Psychiatric ServicesPublisher: American Psychiatric Association PublishingVol: 73Issue #: 12Start Page: 1389End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ps.202100524Citation Count: 10
- Impairment of amacrine starburst cells and their synaptic contacts with dopaminergic cells could explain motion perception disturbances in Parkinson's disease2022RESTRICTEDTitle: Impairment of amacrine starburst cells and their synaptic contacts with dopaminergic cells could explain motion perception disturbances in Parkinson's diseaseJournal Name: Acta OphthalmologicaPublisher: WileyVol: 100Issue #: S275Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1755-3768.2022.0786Citation Count: 0
- Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease2022RESTRICTEDTitle: Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s diseaseJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 29Issue #: 12Start Page: 1637End Page: 1652.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.stem.2022.11.010Best OA location URL: https://doi.org/10.1016/j.stem.2022.11.010Citation Count: 44
-
RESTRICTEDTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Best OA location URL: http://bura.brunel.ac.uk/bitstream/2438/27655/1/FullText.pdfCitation Count: 0
-
RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 4
- Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology2022RESTRICTEDTitle: Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 175Issue #:Start Page: 105925End Page: 105925Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105925Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105925Citation Count: 9
- Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)2022RESTRICTEDTitle: Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 139End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.002Best OA location URL: http://www.prd-journal.com/article/S1353802022002553/pdfCitation Count: 6
-
RESTRICTEDTitle: Nano drug delivery systems for antisense oligonucleotides (ASO) therapeuticsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 352Issue #:Start Page: 861End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2022.10.050Citation Count: 22
-
RESTRICTEDTitle: Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigationJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 100Issue #:Start Page: 501End Page: 510Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleep.2022.09.025Best OA location URL: https://doi.org/10.1016/j.sleep.2022.09.025Citation Count: 5
-
RESTRICTEDTitle: Orchestration of selective autophagy by cargo receptorsJournal Name: Current BiologyPublisher: Elsevier BVVol: 32Issue #: 24Start Page: R1357End Page: R1371Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cub.2022.11.002Best OA location URL: https://doi.org/10.1016/j.cub.2022.11.002Citation Count: 32
-
RESTRICTEDTitle: P5B-ATPases in the mammalian polyamine transport system and their role in diseaseJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchPublisher: Elsevier BVVol: 1869Issue #: 12Start Page: 119354End Page: 119354Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oa, publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bbamcr.2022.119354Best OA location URL: https://doi.org/10.1016/j.bbamcr.2022.119354Citation Count: 11
-
RESTRICTEDTitle: Parkinson’s disease drug hunters think outside the α-synuclein boxJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 12Start Page: 1705End Page: 1707Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41587-022-01610-wCitation Count: 1
- Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s disease2022RESTRICTEDTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 3
-
RESTRICTEDTitle: Pompe disease treated before birthJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 12Start Page: 1707End Page: 1707Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41587-022-01621-7Citation Count: 0
-
RESTRICTEDTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 2
- REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease2022RESTRICTEDTitle: REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's diseaseJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 143Issue #:Start Page: 104897End Page: 104897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104897Citation Count: 1
- Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset2022RESTRICTEDTitle: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI datasetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 90End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019Citation Count: 7